ARES shorts keep building after earnings — but the stock shrugs
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Ares Management Corporation just posted its June 8 results, gained nearly 4% on the day, and yet short sellers responded by pressing harder — a tension that defines where the stock sits heading into the summer.
Short interest tells a story of persistent and accelerating conviction on the bear side. At 8.35% of the free float, it has climbed 11% in a week and 25% over the past month — the sharpest sustained build in the trailing 30-day window. The ORTEX short score hit 58.6 on June 9, its highest reading in the dataset, continuing a grind that began around 51 in late May. That said, the borrow market hasn't tightened enough to create mechanical pressure. Cost to borrow has edged up to 0.65%, about 19% above where it was a month ago, but remains cheap in absolute terms — shorts carry the position at minimal cost. Availability has narrowed from above 650% in early May to 286% now, which is tighter than it was but still firmly in the range where a forced-cover event is a distant prospect. Shorts are building cheaply, with room to keep building. Options, meanwhile, are running near their 20-day average: the put/call ratio of 1.16 is slightly below that mean and well within a standard deviation — no obvious call of caution or enthusiasm from derivatives traders.
The Street, broadly speaking, remains constructive. Most recent analyst activity has involved trimming price targets rather than changing ratings, with a cluster of Overweight and Buy calls intact even after cuts. TD Cowen lowered to $144 in mid-May while keeping its Buy. Oppenheimer came down a point to $146, also maintaining Outperform. Barclays actually raised its target to $140 after the May 4 results. JP Morgan holds Overweight but cut to $144 from $188 in late April — a large reset on valuation that reflects the broader de-rating in the sector. The consensus mean target is $145, implying roughly 11% upside to the current $130.61. The earnings growth scorecard looks strong on a forward 12-month basis, ranking in the 91st percentile for projected EPS increase — but near-term momentum is softer, with the 90-day EPS revision score in the 21st percentile. The bull case rests on AUM growth, institutional demand for alternatives, and the earnings power of a diversified credit platform. The bear case centres on potential multiple compression, private credit risks, and the stock's premium price-to-book of 6.7x.
On the institutional side, the most notable recent move is Wellington Management adding over 5.3 million shares, bringing its position to 11.2 million shares (roughly 5% of outstanding). Capital Research also added 2.96 million shares in May, now at 6.6%. These are sizable additions from active managers, and they sit in interesting contrast to the simultaneous build in short positions — institutional buyers and short sellers are reaching different conclusions from the same fundamental picture.
The earnings record is relevant context. ARES gained 3.9% on June 8 after the Q1 release, following a 3.3% jump after its February earnings and a 2.2% gain after May 1 results. Three positive one-day reactions in a row, all running in the 2-4% range. The next event is scheduled for July 31. Whether the short build reflects a genuine fundamental thesis or a fade-the-positive-reaction trade heading into that print is the question worth tracking over the next several weeks.
Stocks in this article
See the live data behind this article on ORTEX.
Open ARES on ORTEX →How this article was generated
- Generated
- 10 Jun 2026, 19:49
- Data as of
- 10 Jun 2026, 19:45
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.